Literature DB >> 7943240

Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.

J Schmidtler1, K Dehne, H D Allescher, V Schusdziarra, M Classen, J J Holst, A Polack, W Schepp.   

Abstract

The intestinal peptide hormone glucagon-like peptide-1 (GLP-1) (7-36) amide is a potent stimulus of H+ production in isolated rat parietal cells, suggesting the presence of specific GLP-1-receptors on this cell type. Our aim was to characterize these receptors. Enzymatically isolated rat gastric mucosal cells (F0) were fractionated by counterflow elutriation, resulting in five fractions (F1-F5) according to increasing cell diameter and parietal cell content (3, 5, 4, 27, 81%). Additional density gradient centrifugation of F4 yielded enriched chief cells (74%; parietal cells: 1%; F6), whereas density gradient centrifugation of F5 almost purified parietal cells (97%; chief cells: 1%; F7). Northern blot of total cellular RNA from F0-F7 with a probe specific for the GLP-1-(7-36) amide receptor revealed two RNA species of 2.7 and 3.6 kb. These messages were present to some extent in small cells (F1, F2), much more pronounced in F5, abundant in F7, barely detectable in F3 and F4, and absent from F6. Cross-linking of 125I-labeled GLP-1-(7-36) amide to parietal cell membranes revealed a single 59-kDa band that was abolished by unlabeled GLP-1-(7-36) amide. Throughout fractions F1-F7 specific binding of 125I-GLP-1-(7-36) amide was correlated with parietal cell content (r = 0.99; P < 0.01) and H+ production ([14C]aminopyrine accumulation) in response to GLP-1-(7-36) amide or histamine (r = 0.96; P < 0.01). Binding was maximal in purified parietal cells (F7), whereas almost no binding was detectable in enriched chief cells (F6). In F7, Scatchard analysis revealed a single class of high-affinity binding sites (KD = 2.8 +/- 0.6 x 10(-10) M, Bmax = 6.8 +/- 1.4 fmol/10(6) cells, 4,096 +/- 793 receptors/parietal cells). The following half-maximal inhibition values were found for GLP-1-(7-36) amide and (1-37) and (1-36) amide: 6.6 +/- 0.9 x 10(-10), 1.4 +/- 0.7 x 10(-7), and 2.6 +/- 0.4 x 10(-7) M, respectively. Pancreatic glucagon, GLP-2, and oxyntomodulin, products of the proglucagon gene, were 3-4 log units less potent displacers while gastric inhibitory peptide, vasoactive intestinal peptide, and secretin were ineffective. We conclude that rat parietal cells are equipped with specific high-affinity receptors for GLP-1-(7-36) amide, which, in addition, are present in as yet unidentified small cells (F1, F2) but not in chief cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943240     DOI: 10.1152/ajpgi.1994.267.3.G423

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release.

Authors:  P L Brubaker; S Efendic; G R Greenberg
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

2.  Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Emilia E Savage; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

3.  Glucagon-like peptide-1: a potent regulator of food intake in humans.

Authors:  J P Gutzwiller; B Göke; J Drewe; P Hildebrand; S Ketterer; D Handschin; R Winterhalder; D Conen; C Beglinger
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

4.  GLP-1 receptor is expressed in human stomach mucosa: analysis of its cellular association and distribution within gastric glands.

Authors:  Efrat Broide; Olga Bloch; Gilad Ben-Yehudah; Dror Cantrell; Haim Shirin; Micha J Rapoport
Journal:  J Histochem Cytochem       Date:  2013-06-26       Impact factor: 2.479

Review 5.  The gut and food intake: an update for surgeons.

Authors:  E Näslund; P M Hellström; J G Kral
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

6.  64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats.

Authors:  Kirsi Mikkola; Mikkola Kirsi; Cheng-Bin Yim; Yim Cheng-Bin; Veronica Fagerholm; Fagerholm Veronica; Tamiko Ishizu; Ishizu Tamiko; Viki-Veikko Elomaa; Elomaa Viki-Veikko; Johan Rajander; Rajander Johan; Jori Jurttila; Jurttila Jori; Tiina Saanijoki; Saanijoki Tiina; Tuula Tolvanen; Tolvanen Tuula; Marko Tirri; Tirri Marko; Eleni Gourni; Gourni Eleni; Martin Béhé; Béhé Martin; Martin Gotthardt; Gotthardt Martin; Jean Claude Reubi; Reubi Jean Claude; Helmut Mäcke; Mäcke Helmut; Anne Roivainen; Roivainen Anne; Olof Solin; Solin Olof; Pirjo Nuutila; Nuutila Pirjo
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

Review 7.  Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides.

Authors:  Rania Abu-Hamdah; Atoosa Rabiee; Graydon S Meneilly; Richard P Shannon; Dana K Andersen; Dariush Elahi
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

Review 8.  Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation.

Authors:  Brent A McLean; Chi Kin Wong; Jonathan E Campbell; David J Hodson; Stefan Trapp; Daniel J Drucker
Journal:  Endocr Rev       Date:  2021-03-15       Impact factor: 19.871

9.  Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia.

Authors:  B Huisamen; S Genade; A Lochner
Journal:  Cardiovasc J Afr       Date:  2008 Mar-Apr       Impact factor: 1.167

Review 10.  The Physiology of the Gastric Parietal Cell.

Authors:  Amy C Engevik; Izumi Kaji; James R Goldenring
Journal:  Physiol Rev       Date:  2019-10-31       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.